Cargando…
From Bioengineering to CRISPR/Cas9 – A Personal Retrospective of 20 Years of Research in Programmable Genome Targeting
Genome targeting of restriction enzymes and DNA methyltransferases has many important applications including genome and epigenome editing. 15–20 years ago, my group was involved in the development of approaches for programmable genome targeting, aiming to connect enzymes with an oligodeoxynucleotide...
Autor principal: | Jeltsch, Albert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5790776/ https://www.ncbi.nlm.nih.gov/pubmed/29434619 http://dx.doi.org/10.3389/fgene.2018.00005 |
Ejemplares similares
-
Adapting CRISPR/Cas9 System for Targeting Mitochondrial Genome
por: Hussain, Syed-Rehan A., et al.
Publicado: (2021) -
Bioengineering of fungal endophytes through the CRISPR/Cas9 system
por: Verma, Vinita, et al.
Publicado: (2023) -
Nanoparticle Delivery of CRISPR/Cas9 for Genome Editing
por: Duan, Li, et al.
Publicado: (2021) -
Applications of CRISPR-Cas9 for advancing precision medicine in oncology: from target discovery to disease modeling
por: Ravichandran, Mirunalini, et al.
Publicado: (2023) -
Early “reduction to practice” of the CRISPR–Cas9 invention in eukaryotic cells
por: Aquino-Jarquin, Guillermo
Publicado: (2022)